Sign In
Buy OXM
$38.14
+0.260 (+0.686%)
At Close: Jun 23, 2026
Eli Lilly Reports MonarchE Data, And Other News: The Good, Bad And Ugly Of Biopharma (NYSE:LLY)
07:44am, Tuesday, 22'nd Sep 2020
Eli Lilly reports positive data for Phase 3 monarchE trial. Soligenix gets boost from Filovirus vaccine antigens data.
Engineers Gate Manager LP Sells 17,095 Shares of Eli Lilly And Co (NYSE:LLY)
06:36am, Tuesday, 22'nd Sep 2020
Engineers Gate Manager LP trimmed its position in Eli Lilly And Co (NYSE:LLY) by 81.4% in the second quarter, HoldingsChannel reports. The firm owned 3,912 shares of the company’s stock after sellin
Eli Lilly CEO: Speed and industry cooperation are aiding coronavirus treatment development
12:11am, Tuesday, 22'nd Sep 2020
"We developed this antibody and got to proof of concept in six months. Usually, that's more than six years," Eli Lilly CEO Dave Ricks said on CNBC's "Mad Money."
Anticancer Drug Team-Ups Show Promise. 4 Stocks That Stand to Gain.
02:42pm, Monday, 21'st Sep 2020
Some of the best news at the European Society for Medical Oncology conference was for breast-cancer patients.
The Week In Cannabis: Mixed Stock Performers, Big Financings, Platform Launches, And More
12:00am, Saturday, 19'th Sep 2020
This was a mixed week for cannabis stocks, with some ETFs in the green and others in the red.
Over the five trading days of the week:
The ETFMG Alternative Harvest ETF (NYSE: MJ...
Initial data from a pair of clinical trials may revive interest in arthritis drugs as COVID-19 treatments
07:48pm, Friday, 18'th Sep 2020
There is some renewed hope for rheumatoid arthritis drugs like Eli Lilly’s Olumiant and Roche’s Actemra as possible COVID-19 treatments after a series of...
Eli Lilly and : Lilly and Amgen Announce Manufacturing Collaboration for COVID-19 Antibody Therapies | MarketScreener
12:59pm, Friday, 18'th Sep 2020Amyris Patent Lawsuit, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:AMRS)
02:07pm, Thursday, 17'th Sep 2020
Amyris Inc. suffers a setback over patent lawsuit.
Lilly and Amgen partner to manufacture potential coronavirus drugs
11:17am, Thursday, 17'th Sep 2020
Eli Lilly has partnered with Amgen to increase the capacity of its experimental C-19 antibody treatment, a day after one of the drug was shown to reduce the need for hospitalization.
Eli Lilly and Amgen to collaborate on COVID-19 antibody therapies
10:41am, Thursday, 17'th Sep 2020
Eli Lilly and Co. undefined and Amgen Inc. undefined said Thursday they will collaborate on COVID-19 antibody treatments as a way to significantly boost...
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
12:00am, Thursday, 17'th Sep 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Sept. 16)
Arena Pharmaceuticals, Inc...
Eli Lilly Posts Positive 'Proof Of Concept Data' From Coronavirus Antibody Treatment Trials
06:26pm, Wednesday, 16'th Sep 2020
The company said it already is manufacturing the drug in hopes upcoming trials continue yielding positive results.
Lilly and Pfizer Are Testing Treatments for Hospitalized Covid Patients
05:57pm, Wednesday, 16'th Sep 2020
Lilly’s anti-inflammatory drug Olumiant reduced hospital stays when combined with Gilead’s remdesivir.
